395 related articles for article (PubMed ID: 26162538)
1. Effect of cardiac resynchronization therapy on patients with heart failure and narrow QRS complexes: a meta-analysis of five randomized controlled trials.
Wang G; Zhao Z; Zhao S; Ding S; Shen S; Wang L
J Interv Card Electrophysiol; 2015 Oct; 44(1):71-9. PubMed ID: 26162538
[TBL] [Abstract][Full Text] [Related]
2. Cardiac-resynchronization therapy in patients with systolic heart failure and QRS interval ≤130 ms: insights from a meta-analysis.
Shah RM; Patel D; Molnar J; Ellenbogen KA; Koneru JN
Europace; 2015 Feb; 17(2):267-73. PubMed ID: 25164431
[TBL] [Abstract][Full Text] [Related]
3. The benefit of cardiac resynchronization therapy and QRS duration: a meta-analysis.
Stavrakis S; Lazzara R; Thadani U
J Cardiovasc Electrophysiol; 2012 Feb; 23(2):163-8. PubMed ID: 21815961
[TBL] [Abstract][Full Text] [Related]
4. Cardiac resynchronization therapy in patients with minimal heart failure: a systematic review and meta-analysis.
Adabag S; Roukoz H; Anand IS; Moss AJ
J Am Coll Cardiol; 2011 Aug; 58(9):935-41. PubMed ID: 21851882
[TBL] [Abstract][Full Text] [Related]
5. Long-term impact of cardiac resynchronization therapy in mild heart failure: 5-year results from the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study.
Linde C; Gold MR; Abraham WT; St John Sutton M; Ghio S; Cerkvenik J; Daubert C;
Eur Heart J; 2013 Sep; 34(33):2592-9. PubMed ID: 23641006
[TBL] [Abstract][Full Text] [Related]
6. Reduced long-term overall mortality in heart failure patients with prolonged QRS treated with CRT combined with ICD vs. heart failure patients with narrow QRS treated with ICD only.
Palmisano P; Accogli M; PisanĂ² EC; Zaccaria M; De Blasi S; Ponzetta MA; Valsecchi S; Milanese G; Lauretti M; Magliari F
Europace; 2016 Sep; 18(9):1374-82. PubMed ID: 26612878
[TBL] [Abstract][Full Text] [Related]
7. Relation of QRS Duration to Clinical Benefit of Cardiac Resynchronization Therapy in Mild Heart Failure Patients Without Left Bundle Branch Block: The Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy Substudy.
Biton Y; Kutyifa V; Cygankiewicz I; Goldenberg I; Klein H; McNitt S; Polonsky B; Ruwald AC; Ruwald MH; Moss AJ; Zareba W
Circ Heart Fail; 2016 Feb; 9(2):e002667. PubMed ID: 26823498
[TBL] [Abstract][Full Text] [Related]
8. An individual patient meta-analysis of five randomized trials assessing the effects of cardiac resynchronization therapy on morbidity and mortality in patients with symptomatic heart failure.
Cleland JG; Abraham WT; Linde C; Gold MR; Young JB; Claude Daubert J; Sherfesee L; Wells GA; Tang AS
Eur Heart J; 2013 Dec; 34(46):3547-56. PubMed ID: 23900696
[TBL] [Abstract][Full Text] [Related]
9. Impact of QRS duration on clinical event reduction with cardiac resynchronization therapy: meta-analysis of randomized controlled trials.
Sipahi I; Carrigan TP; Rowland DY; Stambler BS; Fang JC
Arch Intern Med; 2011 Sep; 171(16):1454-62. PubMed ID: 21670335
[TBL] [Abstract][Full Text] [Related]
10. Cardiac resynchronization therapy in patients with heart failure and a QRS complex <120 milliseconds: the Evaluation of Resynchronization Therapy for Heart Failure (LESSER-EARTH) trial.
Thibault B; Harel F; Ducharme A; White M; Ellenbogen KA; Frasure-Smith N; Roy D; Philippon F; Dorian P; Talajic M; Dubuc M; Guerra PG; Macle L; Rivard L; Andrade J; Khairy P;
Circulation; 2013 Feb; 127(8):873-81. PubMed ID: 23388213
[TBL] [Abstract][Full Text] [Related]
11. Opportunity to increase life span in narrow QRS cardiac resynchronization therapy recipients by deactivating ventricular pacing: evidence from randomized controlled trials.
Sohaib SM; Finegold JA; Nijjer SS; Hossain R; Linde C; Levy WC; Sutton R; Kanagaratnam P; Francis DP; Whinnett ZI
JACC Heart Fail; 2015 Apr; 3(4):327-36. PubMed ID: 25770400
[TBL] [Abstract][Full Text] [Related]
12. Metaanalysis on effects of cardiac resynchronization therapy in heart failure patients with narrow QRS complex.
Jeevanantham V; Zareba W; Navaneethan S; Fitzgerald D; Yu CM; Achilli A; Bax J; Daubert J
Cardiol J; 2008; 15(3):230-6. PubMed ID: 18651415
[TBL] [Abstract][Full Text] [Related]
13. [A systematic review and meta-analysis on efficacy and safety of cardiac resynchronization therapy alone or in combination with implantable cardioversion defibrillation in patients with mild to severe heart failure].
Tu RH; Peng RL; Zhong GQ; Wu WF; Chen L; Liang YY
Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Feb; 41(2):161-70. PubMed ID: 23710749
[TBL] [Abstract][Full Text] [Related]
14. Association of persistent or worsened echocardiographic dyssynchrony with unfavourable clinical outcomes in heart failure patients with narrow QRS width: a subgroup analysis of the EchoCRT trial.
Gorcsan J; Sogaard P; Bax JJ; Singh JP; Abraham WT; Borer JS; Dickstein K; Gras D; Krum H; Brugada J; Robertson M; Ford I; Holzmeister J; Ruschitzka F
Eur Heart J; 2016 Jan; 37(1):49-59. PubMed ID: 26321238
[TBL] [Abstract][Full Text] [Related]
15. A randomized study of cardiac resynchronization therapy defibrillator versus dual-chamber implantable cardioverter-defibrillator in ischemic cardiomyopathy with narrow QRS: the NARROW-CRT study.
Muto C; Solimene F; Gallo P; Nastasi M; La Rosa C; Calvanese R; Iengo R; Canciello M; Sangiuolo R; Diemberger I; Ciardiello C; Tuccillo B
Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):538-45. PubMed ID: 23592833
[TBL] [Abstract][Full Text] [Related]
16. Sex Differences in Long-Term Outcomes With Cardiac Resynchronization Therapy in Mild Heart Failure Patients With Left Bundle Branch Block.
Biton Y; Zareba W; Goldenberg I; Klein H; McNitt S; Polonsky B; Moss AJ; Kutyifa V;
J Am Heart Assoc; 2015 Jun; 4(7):. PubMed ID: 26124205
[TBL] [Abstract][Full Text] [Related]
17. Long-Term Extrapolation of Clinical Benefits Among Patients With Mild Heart Failure Receiving Cardiac Resynchronization Therapy: Analysis of the 5-Year Follow-Up From the REVERSE Study.
Gold MR; Padhiar A; Mealing S; Sidhu MK; Tsintzos SI; Abraham WT
JACC Heart Fail; 2015 Sep; 3(9):691-700. PubMed ID: 26277764
[TBL] [Abstract][Full Text] [Related]
18. Benefits of cardiac resynchronization therapy for heart failure patients with narrow QRS complexes and coexisting systolic asynchrony by echocardiography.
Yu CM; Chan YS; Zhang Q; Yip GW; Chan CK; Kum LC; Wu L; Lee AP; Lam YY; Fung JW
J Am Coll Cardiol; 2006 Dec; 48(11):2251-7. PubMed ID: 17161255
[TBL] [Abstract][Full Text] [Related]
19. Impact of ejection fraction on the clinical response to cardiac resynchronization therapy in mild heart failure.
Linde C; Daubert C; Abraham WT; St John Sutton M; Ghio S; Hassager C; Herre JM; Bergemann TL; Gold MR;
Circ Heart Fail; 2013 Nov; 6(6):1180-9. PubMed ID: 24014828
[TBL] [Abstract][Full Text] [Related]
20. The interaction of sex, height, and QRS duration on the effects of cardiac resynchronization therapy on morbidity and mortality: an individual-patient data meta-analysis.
Linde C; Cleland JGF; Gold MR; Claude Daubert J; Tang ASL; Young JB; Sherfesee L; Abraham WT
Eur J Heart Fail; 2018 Apr; 20(4):780-791. PubMed ID: 29314424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
